Evidence map›Paper›PMID 41942762›Full record

ArticleJournal of neuro-oncology2026

Multiple presentations: a single pathology, primary central nervous system lymphoma (PCNSL). A multicenter study.

Alberto González-Aguilar, Alicia Jiménez-Quintero, Alexandra Díaz-Alba, Gabriela Macías-Arriaga, Bernardo Cacho-Díaz, Ignacio Reyes-Moreno, Guillermo A Gutiérrez-Aceves, Ulises García-González, Vicente Guerrero-Juárez, Encarnación Ramírez Manuel de Jesús and 5 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alberto González-AguilarDepartamento NeurOncología Centro Médico Naval (CEMENAV). Secretaría de Marina, Mexico City, México. mdalbertogonzalez@outlook.com.
Alicia Jiménez-QuinteroFacultad de Estudios Superiores Zaragoza. UNAM, Mexico City, Mexico.
Alexandra Díaz-AlbaInstituto Jaliciense de Cancerología (IJC). Zapopan, Mexico City, México.
Gabriela Macías-ArriagaServicio de Neuroradiología Instituto Nacional de Rehabilitación (INR), Mexico City, Mexico.
Bernardo Cacho-DíazServicio NeurOncología Instituto Nacional de Cancerología (INCAN), Mexico City, México.
Ignacio Reyes-MorenoCentro Médico American British Cowdray, Mexico City, Mexico.
Guillermo A Gutiérrez-AcevesCentro Médico American British Cowdray, Mexico City, Mexico.
Ulises García-GonzálezDepartamento de Neurocirugía, Hospital Central Sur de Alta Especialidad Pemex Picacho, Mexico City, Mexico.
Vicente Guerrero-JuárezDepartamento de Neurología INNN, Mexico City, Mexico.
Encarnación Ramírez Manuel de JesúsDepartment of Human Anatomy and Histology, Institute of Clinical Medicine Named After N.V. Sklifo-Sovskiy, Moscow, Russia.
Álvaro Antonio-HerediaDepartamento NeurOncología Centro Médico Naval (CEMENAV). Secretaría de Marina, Mexico City, México.
Lizeth Zertuche-OrtuñoDepartamento NeurOncología Centro Médico Naval (CEMENAV). Secretaría de Marina, Mexico City, México.
Gervith Reyes SotoServicio NeurOncología Instituto Nacional de Cancerología (INCAN), Mexico City, México.
Gabriel Huerta HernándezEl Centro Médico Nacional "20 de Noviembre" Instituto de Seguridad y Servicio Social para los Trabajadores del Estado, Mexico City, Mexico.
Sebastián Gutiérrez-CasillasDepartamento NeurOncología Centro Médico Naval (CEMENAV). Secretaría de Marina, Mexico City, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary central nervous system lymphoma (PCNSL) is an uncommon extranodal non-Hodgkin lymphoma confined to the brain, spinal cord, leptomeninges, and eyes. Despite its characteristic histology, its neuroimaging appearance is remarkably heterogeneous and often mimics other brain tumors or inflammatory diseases.

methodsWe performed a retrospective analysis of patients diagnosed with PCNSL by members of the Mexican Neuro-Oncology Group. Only cases with histopathological confirmation and pre-treatment contrast-enhanced MRI were included. Lesions were classified according to radiological pattern, number, enhancement characteristics, and anatomical location.

resultsA total of 133 patients met the inclusion criteria. The mean age was 51 years, and 54.2% were men. Seventeen distinct radiological presentation patterns were identified: snowball (58.2%), lymphomatosis cerebri (2.3%), ghost tumor (3.0%), subdural hematoma–like (0.8%), pachymeningeal (2.3%), Ring lesion (5.3%), intraventricular (1.7%), uveal–meningeal (5.9%), isolated intraocular (3.8%), CLIPPERS-like (1.5%), pseudo–multiple sclerosis (3.8%), pseudometastatic (6.0%), primary meningeal (1.5%), pseudoschwannoma (0.8%), pseudomeningioma (2.3%), pseudoadenoma (0.8%), and spinal cord form (0.8%). Deep or periventricular involvement was observed in more than half of the cases.

conclusionsPCNSL exhibits a broad spectrum of neuroradiological patterns that may complicate its recognition. Identifying these atypical presentations is essential to avoid diagnostic delays. Imaging alone is insufficient to establish the diagnosis, underscoring the need for histopathological confirmation. To our knowledge, this represents the largest Latin American series describing the neuroradiological heterogeneity of PCNSL.

Indexed as

Central Nervous System NeoplasmsLymphomaAdolescentAdultAgedAged, 80 and overFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesYoung AdultBrain tumorsDifume large B-cell lymphomaMRINeuroimagingNeurooncologyNeuroradiologyPrimary CNS lymphoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.